Zulkhah Noor, D. L. Kusindarta, A. Sadewa, D. S. Heriyanto, D. R. Hadiati, Mustofa
{"title":"Acute toxicity of the galactagogue phytomedicine containing Sauropus androgynous, Trigonella foenumgraecum, and Moringa oleifera","authors":"Zulkhah Noor, D. L. Kusindarta, A. Sadewa, D. S. Heriyanto, D. R. Hadiati, Mustofa","doi":"10.29090/psa.2022.04.21.217","DOIUrl":null,"url":null,"abstract":"This study aims to evaluate acute toxicity of the herbal preparation on rats as an early step to evaluate its safety. This study used 25 females Rattus norvegicus strain Sprague Dawley rats aged 8 weeks with a body weight of at least 120 g divided into 5 groups of doses of herbal preparation (0/aquadest, 50, 300, 2,000, 5,000) mg/kg BW. After administration of the herbal preparation, rats were observed using a camera continuously for 14 days and manual observation intensively for the first 24 hours and then once a day for up to 14 days. The toxic effects including death, behavioral changes, neural symptoms, and other abnormalities were recorded. The weight of the rats was monitored every three days. On the 15 th day, the rats were sacrificed to collect vital organs for macroscopic and histopathological examinations. The LD 50 was estimated based on OECD Guideline. No mortality and significant toxicity signs in any of the rats after receiving the herbal formula at highest dose of 5000 mg/kg was reported during the 14-day observation period. Body weight and organ weight did not show significant variation between controls and treatment groups. In addition, no abnormalities of liver, heart and lungs were also observed in macroscopic and histopathological examinations. In conclusion, the herbal preparation shows the LD 50 of greater than 5,000 mg/kg can be classified as category 5 or unclassified. Further sub chronic toxicity study will be conducted to evaluate its safety after repeated exposure.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.04.21.217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to evaluate acute toxicity of the herbal preparation on rats as an early step to evaluate its safety. This study used 25 females Rattus norvegicus strain Sprague Dawley rats aged 8 weeks with a body weight of at least 120 g divided into 5 groups of doses of herbal preparation (0/aquadest, 50, 300, 2,000, 5,000) mg/kg BW. After administration of the herbal preparation, rats were observed using a camera continuously for 14 days and manual observation intensively for the first 24 hours and then once a day for up to 14 days. The toxic effects including death, behavioral changes, neural symptoms, and other abnormalities were recorded. The weight of the rats was monitored every three days. On the 15 th day, the rats were sacrificed to collect vital organs for macroscopic and histopathological examinations. The LD 50 was estimated based on OECD Guideline. No mortality and significant toxicity signs in any of the rats after receiving the herbal formula at highest dose of 5000 mg/kg was reported during the 14-day observation period. Body weight and organ weight did not show significant variation between controls and treatment groups. In addition, no abnormalities of liver, heart and lungs were also observed in macroscopic and histopathological examinations. In conclusion, the herbal preparation shows the LD 50 of greater than 5,000 mg/kg can be classified as category 5 or unclassified. Further sub chronic toxicity study will be conducted to evaluate its safety after repeated exposure.
Pharmaceutical Sciences AsiaPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍:
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.